tiprankstipranks
Lumos Pharma (LUMO)
NASDAQ:LUMO
US Market
Holding LUMO?
Track your performance easily

Lumos Pharma (LUMO) Technical Analysis

346 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Lumos Pharma’s (LUMO) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Lumos Pharma is a Buy.
Lumos Pharma’s (LUMO) 20-Day exponential moving average is 4.29, while Lumos Pharma’s (LUMO) share price is $4.31, making it a Buy.
Lumos Pharma’s (LUMO) 50-Day exponential moving average is 4.01, while Lumos Pharma’s (LUMO) share price is $4.31, making it a Buy.

Lumos Pharma (LUMO) Pivot Points

Nov 23, 2024, 07:59 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.29
4.31
4.31
4.33
4.33
4.35
4.35
Fibonacci
4.31
4.31
4.32
4.33
4.33
4.34
4.35
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lumos Pharma (LUMO) Moving Averages

Nov 23, 2024, 07:59 PM
Period
Simple
Exponential
MA5
4.33Buy
4.33Buy
MA10
4.33Sell
4.33Buy
MA20
4.36Sell
4.29Buy
MA50
4.07Buy
4.01Buy
MA100
3.29Buy
3.61Buy
MA200
3.00Buy
3.27Buy
Lumos Pharma’s (LUMO) 10-Day exponential moving average is 4.33, while Lumos Pharma’s (LUMO) share price is $4.31, making it a Buy.
Lumos Pharma’s (LUMO) 100-Day exponential moving average is 3.61, while Lumos Pharma’s (LUMO) share price is $4.31, making it a Buy.
Lumos Pharma’s (LUMO) stock price is $4.31 and Lumos Pharma’s (LUMO) 50-day simple moving average is 4.07, creating a Buy signal.
Lumos Pharma’s (LUMO) stock price is $4.31 and Lumos Pharma’s (LUMO) 100-day simple moving average is 3.29, creating a Buy signal.
Lumos Pharma’s (LUMO) stock price is $4.31 and Lumos Pharma’s (LUMO) 200-day simple moving average is 3.00, creating a Buy signal.

Lumos Pharma (LUMO) Technical Indicators

Nov 23, 2024, 07:59 PM
Name
Value
Implied Action
RSI (14)
56.39
Neutral
STOCH (9,6)
40.35
Neutral
STOCHRSI (14)
33.18
Neutral
MACD (12,26)
0.08
Buy
ADX (14)
11.37
Buy
Williams %R
-62.96
Buy
CCI (14)
-57.17
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
30.82
Neutral
ROC
-0.92
Sell
Lumos Pharma’s (LUMO) Relative Strength Index (RSI) is 56.39, creating a Neutral signal.
Lumos Pharma’s (LUMO) Trend Strength Indicator (ADX) is 11.37, creating a Buy signal.
Lumos Pharma’s (LUMO) Commodity Channel Index (CCI) is -57.17, creating a Neutral signal.
Lumos Pharma’s (LUMO) Price Rate of Change (ROC) is -0.92, creating a Sell signal.

FAQ

Is LUMO a Buy, Hold, or Sell?
Based on LUMO’s technical indicators, LUMO is a Buy.
    What is LUMO’s RSI (14)?
    LUMO’s RSI (14) is 56.39, which suggests LUMO is a Neutral.
      What is LUMO’s MACD?
      LUMO’s MACD is 0.08, which suggests LUMO is a Buy.
        What is LUMO’s 5-day moving average?
        LUMO’s 5-day moving average is 4.33, which suggests LUMO is a Buy.
          What is LUMO’s 20-day moving average?
          LUMO 20-day moving average is 4.36, which suggests LUMO is a Sell.
            What is LUMO’s 50-day moving average?
            LUMO’s 50-day moving average is 4.07, which suggests LUMO is a Buy.
              What is LUMO’s 200-day moving average?
              LUMO’s 200-day moving average is 3.00, which suggests LUMO is a Buy.
                What is LUMO’s Williams % R (14)?
                LUMO’s Williams % R (14) is -62.96, which suggests LUMO is a Buy.
                  What is LUMO’s CCI (14)?
                  LUMO’s CCI (14) is -57.17, which suggests LUMO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis